UBS’s Amedisys AMED Stock Holding History

UBS’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-300	Closed	-$4K	–	10390
2013 Q4	$4K	Hold	300	–	–	﹤0.01%	9676
2013 Q3	$5K	Sell	300 -6,400	-96%	-$94.9K	﹤0.01%	9377
2013 Q2	$78K	Buy	+6,700	New	+$76.7K	﹤0.01%	6191

Other funds holding AMED

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JCG

JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS's AMED Position: Q3 2014 in Review

UBS increased its Amedisys (AMED) stake by 10% in Q3 2014, buying an estimated $106K and bringing the position to 58,448 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #3429.

UBS first reported a position in AMED in Q2 2013 and has held it in 6 quarters since. 125 funds tracked by Wall St. Rank hold AMED as of Q3 2014.

UBS held 58,448 shares of Amedisys worth $1.18M as of Q3 2014.
UBS bought 5,480 Amedisys shares in Q3 2014, an estimated $106K.
Amedisys made up ﹤0.01% of UBS's portfolio in Q3 2014, its #3429 holding.
UBS first reported a position in Amedisys in Q2 2013 and has held it in 6 quarters since.
125 funds tracked by Wall St. Rank held Amedisys as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.